Company introduction
VIRTUALMAN predicts experimental results with clear optimization guidelines in the pre-clinical drug development phase. Our service combines prediction models, powered by deep learning, with pharmaceutical expertise. Compared with other prediction tools, our models reduce the error rate by 60% and recommend modified molecules.
Our clients not only save time and costs from unnecessary experiments, but also obtain insights from the revolutionary Explainable AI models. Contrary to the traditional black-box AI tools, our models demonstrate the results with explanation that guides R&D teams to win the game fast.
VIRTUALMAN commits to accelerate the drug development together with our clients in the pre-clinical phase. From web-based analytical tools for various endpoints to the latest ADDD (AI-Driven Drug Development) platform, our clients can select the products tailored to their needs with assistance from our seasoned consultants.
Deploying VIRTUALMAN solutions in the existing process of drug development is completely hassle-free. Our clients can directly use the standard models right after logging in to the online platform, which charges them by usage. They can also require proprietary models or AI deployment strategy fit into specific procedures.
We have close cooperation with pharmaceutical companies in both on-demand cloud-based services and customized projects. To know how VIRTUALMAN can facilitate your pre-clinical drug development, contact us via www.virtualman.ai or consult our CRO partners for more details.
